celecoxib has been researched along with diclofenac sodium in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abdi, K; Amini, M; Dehpour, AR; Ghahremani, MH; Navidpour, L; Shafaroodi, H; Shafiee, A | 1 |
| Bhatt, HG; Chhabria, MT; Oza, PM; Raval, HG | 1 |
| Anderluh, M; Brunskole, M; Gobec, S; Lanisnik Rizner, T; Stefane, B; Stojan, J; Zorko, K | 1 |
| Eissa, AA; Farag, NA; Soliman, GA | 1 |
| Abdel-Aziz, AA; Abdel-Aziz, NI; Asiri, YA; El-Azab, AS; El-Sayed, MA; Eltahir, KE | 1 |
| Abdel-Aziz, AA; Abdel-Aziz, NI; El-Azab, AS; El-Sayed, MA; ElTahir, KE | 1 |
| Abbas, SE; Awadallah, FM; Ibrahin, NA; Kamel, GM; Said, EG | 1 |
| Baheti, KG; Ganorkar, SB; Shelke, RU; Yewale, SB | 1 |
| Abdel-Aziz, AA; Abu El-Enin, MA; Al-Obaid, AM; Al-Suwaidan, IA; Alanazi, AM; El-Azab, AS; ElTahir, KE; Maarouf, AR | 1 |
| Ahmed, EM; Khalil, NA; Mohamed, KO; Nissan, YM; Zaitone, SA | 1 |
| Abdel-Daim, MM; Elshihawy, HA; Ghareb, N; Helal, MA | 1 |
| Abdel-Ghany, YS; Alaaeddine, R; Alaeddine, LM; Belal, ASF; El-Yazbi, AF; Hazzaa, A; Ismail, A; Moussa, G; Nassra, R | 1 |
| Abonia, R; Marín-Ocampo, L; Sepúlveda-Arias, JC; Veloza, LA | 1 |
| Alaaeddine, R; Belal, ASF; Bruning, JB; Chua, BSK; El-Yazbi, AF; Elzahhar, PA; Frkic, RL; Ibrahim, TM; Ismail, A; Knape, T; Labib, H; Nassra, R; von Knethen, A; Wallner, N | 1 |
| Arafa, RK; El-Sayed, NA; Nour, MS; Salem, MA | 1 |
| Abdel-Moty, SG; Abou-Ghadir, OMF; Ali, AY; Maghraby, MT; Salem, OIA | 1 |
| Abd El Wahab, SM; Alaaeddine, R; Allam, RM; Angeli, A; Belal, ASF; Daabees, H; Eid, AH; El-Hawash, SA; El-Yazbi, AF; Elagawany, M; Elzahhar, PA; Hegazy, RR; Helmy, MW; Supuran, CT | 1 |
| Neha, K; Wakode, S | 1 |
2 review(s) available for celecoxib and diclofenac sodium
| Article | Year |
|---|---|
Anti-inflammatory activity of triazine derivatives: A systematic review.
Topics: Animals; Anti-Inflammatory Agents; Humans; Inflammation; Structure-Activity Relationship; Triazines | 2019 |
Contemporary advances of cyclic molecules proposed for inflammation.
Topics: Animals; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Humans; Inflammation; Molecular Structure; Structure-Activity Relationship | 2021 |
16 other study(ies) available for celecoxib and diclofenac sodium
| Article | Year |
|---|---|
Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
Topics: Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Design; Lactones; Molecular Structure; Pyrazoles; Rats; Solubility; Stomach; Sulfonamides; Sulfones; Water | 2006 |
Synthesis and biological evaluation of some 5-ethoxycarbonyl-6-isopropylamino-4-(substitutedphenyl)aminopyrimidines as potent analgesic and anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Chemistry, Physical; Indicators and Reagents; Mice; Pain Measurement; Propylamines; Pyrimidines; Stomach Ulcer | 2007 |
Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening.
Topics: Amino Acid Sequence; Ascomycota; Benzopyrans; Enzyme Inhibitors; Fungal Proteins; Melanins; Models, Molecular; Molecular Sequence Data; Oxidoreductases Acting on CH-CH Group Donors; Recombinant Proteins; Structural Homology, Protein; Substrate Specificity | 2008 |
Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Catalytic Domain; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Extremities; Fever; Male; Mice; Models, Molecular; Protein Binding; Rats | 2009 |
Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Computer Simulation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Design; Edema; Hydrazones; Pyrazoles; Rats | 2011 |
Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Design; Enzyme Activation; Inhibitory Concentration 50; Models, Molecular; Protein Binding; Pyrazoles; Quantitative Structure-Activity Relationship; Rats | 2012 |
New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry Techniques, Synthetic; Edema; Female; Male; Pyrimidines; Quinazolinones; Rats; Ulcer | 2012 |
Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Celecoxib; Diclofenac; Dose-Response Relationship, Drug; Edema; Molecular Structure; Protein Binding; Pyrazoles; Pyrimidinones; Rats; Sulfonamides | 2012 |
Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
Topics: Animals; Anti-Inflammatory Agents; Benzenesulfonamides; Binding Sites; Catalytic Domain; Cyclization; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Edema; Hydrogen Bonding; Imides; Molecular Docking Simulation; Rats; Structure-Activity Relationship; Sulfonamides | 2013 |
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytokines; Dose-Response Relationship, Drug; Edema; Humans; Mice; Models, Molecular; Molecular Structure; Pyrazolones; Pyridazines; Structure-Activity Relationship | 2014 |
Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Celecoxib; Cyclization; Cyclooxygenase 2 Inhibitors; Enzyme Assays; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Pyrazoles; Pyridazines; Quantum Theory; Quinones; Spodoptera; Ultrasonic Waves | 2017 |
Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 15-Lipoxygenase; Cell Differentiation; Click Chemistry; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Lipoxygenase Inhibitors; Macrophages; Molecular Docking Simulation; Molecular Structure; Quinazolinones; Rats; Rats, Wistar; Structure-Activity Relationship; Sulfhydryl Compounds; Tumor Cells, Cultured | 2018 |
Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 15-Lipoxygenase; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Ligands; Molecular Docking Simulation; PPAR gamma; Protein Binding; Thiazolidinediones | 2019 |
New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Models, Molecular; Molecular Structure; Oxadiazoles; Protein Kinase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 15-Lipoxygenase; Benzimidazoles; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Edema; Lipoxygenase Inhibitors; Male; Molecular Structure; Rats; Structure-Activity Relationship; Thiazoles | 2020 |
Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
Topics: Antineoplastic Agents; Arachidonate 15-Lipoxygenase; Carbonic Anhydrases; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship; Triazoles | 2020 |